Skip to main content

Advertisement

SpringerLink
Log in

Radiotherapy for metastatic brain tumors

  • Review Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Radiation therapy has been the most important treatment for patients with brain metastases. With the development of stereotactic irradiation, conventional radiotherapy is being employed less often. However, whole-brain radiation therapy (WBRT) is still the mainstay of treatment for multiple brain metastases. This article reviews the results of conventional radiotherapy for brain metastases, and discusses optimal treatment, including fractionation schedules and combination with stereotactic irradiation, and the effects on neurocognitive functions. The authors conclude that WBRT with 30 Gy in ten fractions is no longer optimal for every patient with multiple brain metastases. WBRT employing appropriate fractionation schedules with or without stereotactic boost should be considered, depending on the patient’s condition, disease status, and expected period of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wen PY, Black PM, Loeffler JS (2001) Metastatic brain cancer. In: DeVita V, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 6th edn. Lippincott, Williams, & Wilkins, Philadelphia, pp 2655–2670

    Google Scholar 

  2. Zimm S, Wampler GL, Stablein D, et al. (1981) Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 48:384–394

    Article  PubMed  CAS  Google Scholar 

  3. Sundstrom JT, Minn H, Lertola KK, et al. (1998) Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med 30:296–299

    Article  PubMed  CAS  Google Scholar 

  4. Khuntia D, Brown P, Li J, Mehta MP (2006) Whole-brain radiotherapy in the management of brain metastases. J Clin Oncol 24:1295–1303

    Article  PubMed  CAS  Google Scholar 

  5. Chao JH, Phillips R, Nickson JJ (1954) Roentgen-ray therapy of cerebral metastases. Cancer 7:682–689

    Article  PubMed  CAS  Google Scholar 

  6. Order SE, Hellman S, Von Essen CF, et al. (1968) Improvement in quality of survival following whole-brain irradiation for brain metastasis. Radiology 91:149–153

    PubMed  CAS  Google Scholar 

  7. Patchell RA, Regine WF (2003) The rationale for adjuvant whole brain radiation therapy with radiosurgery in the treatment of single brain metastases. Technol Cancer Res Treat 2:111–115

    PubMed  Google Scholar 

  8. Patchell RA, Tibbs PA, Regine WF, et al. (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485–1489

    Article  PubMed  CAS  Google Scholar 

  9. Arbit E, Wronski M, Burt M, et al. (1995) The treatment of patients with recurrent brain metastases: a retrospective analysis of 109 patients with nonsmall cell lung cancer. Cancer 76:765–773

    Article  PubMed  CAS  Google Scholar 

  10. Coia LR (1992) The role of radiation therapy in the treatment of brain metastases. Int J Radiat Oncol Biol Phys 23:229–238

    PubMed  CAS  Google Scholar 

  11. Kurtz JM, Gelber R, Brady LW, et al. (1981) The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 7:891–895

    PubMed  CAS  Google Scholar 

  12. Borgelt B, Gelber R, Kramer S, et al. (1980) The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6:1–9

    PubMed  CAS  Google Scholar 

  13. Borgelt B, Gelber R, Larson M, et al. (1981) Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 7:1633–1638

    PubMed  CAS  Google Scholar 

  14. Murray KJ, Scott C, Greenberg HM, et al. (1997) A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 39:571–574

    PubMed  CAS  Google Scholar 

  15. Harwood AR, Simson WJ (1977) Radiation therapy of cerebral metastases: a randomized prospective clinical trial. Int J Radiat Oncol Biol Phys 2:1091–1094

    PubMed  CAS  Google Scholar 

  16. Chatani M, Teshima T, Hata K, et al. (1986) Prognostic factors in patients with brain metastases from lung carcinoma. Strahlenther Onkol 162:157–161

    PubMed  CAS  Google Scholar 

  17. Haie-Meder C, Pellae-Cosset B, Laplanche A, et al. (1993) Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases. Radiother Oncol 26:111–116

    Article  PubMed  CAS  Google Scholar 

  18. Chatani M, Matayoshi Y, Masaki N, et al. (1994) Radiation therapy for brain metastases from lung carcinoma: prospective randomized trial according to the level of lactate dehydrogenase. Strahlenther Onkol 170:155–161

    PubMed  CAS  Google Scholar 

  19. Tsao MN, Lloyd NS, Wong RKS, et al. (2005) Radiotherapeutic management of brain metastases: a systematic review and metaanalysis. Cancer Treatment Rev 31:256–273

    Article  Google Scholar 

  20. Bezjak A, Adam J, Barton R, et al. (2002) Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 38:487–496

    Article  PubMed  CAS  Google Scholar 

  21. DeAngelis LM, Delattre JY, Posner JB (1989) Radiation-induced dementia in patients cured of brain metastases. Neurology 39: 789–796

    PubMed  CAS  Google Scholar 

  22. Marcou Y, Lindquist C, Adams C, et al. (2001) What is the optimal therapy of brain metastases? Clin Oncol 13:105–111

    CAS  Google Scholar 

  23. Serizawa T (2009) Radiosurgery for metastatic brain tumor. Int J Clin Oncol 14:289–298

    Article  Google Scholar 

  24. Shibamoto Y, Yukawa Y, Tsutsui K, et al. (1986) Variation in the hypoxic fraction among mouse tumors of different types, sizes, and sites. Jpn J Cancer Res 77:908–915

    PubMed  CAS  Google Scholar 

  25. Tomita N, Shibamoto Y, Ito M, et al. (2008) Biological effect of intermittent radiation exposure in vivo: recovery from sublethal damage versus reoxygenation. Radiother Oncol 86:369–374

    Article  PubMed  CAS  Google Scholar 

  26. Shibamoto Y, Ito M, Sugie C, et al. (2004) Recovery from sublethal damage during intermittent exposures in cultured tumor cells: implications for dose modification in radiosurgery and IMRT. Int J Radiat Oncol Biol Phys 59:1484–1490

    PubMed  Google Scholar 

  27. Shaw E, Scott C, Suh J, et al. (2003) RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases database. J Clin Oncol 21:2364–2371

    Article  PubMed  CAS  Google Scholar 

  28. Shibamoto Y, Sugie C, Ito M, et al. (2004) The Japanese experiences with hypoxia-targeting pharmacoradiotherapy: from hypoxic cell sensitizers to radiation-activated prodrugs. Expert Opin Pharmacother 5:2459–2467

    Article  PubMed  CAS  Google Scholar 

  29. Patel M, McCully C, Godwin K, et al. (2003) Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in nonhuman primates. J Neurooncol 61:203–207

    Article  PubMed  Google Scholar 

  30. Abrey LE, Olson JD, Raizer JJ, et al. (2001) A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol 53:259–265

    Article  PubMed  CAS  Google Scholar 

  31. Christodoulou C, Bafaloukos D, Kosmidis P, et al. (2001) Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Ann Oncol 12:249–254

    Article  PubMed  CAS  Google Scholar 

  32. Antonadou D, Paraskevaidis M, Sarris G, et al. (2002) Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 20:3644–3650

    Article  PubMed  CAS  Google Scholar 

  33. Agarwala SS, Kirkwood JM, Gore M, et al. (2004) Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study. J Clin Oncol 22:2101–2107

    Article  PubMed  CAS  Google Scholar 

  34. Siena S, Landonio G, Baietta E, et al. (2003) Multi-center phase II study of temozolomide therapy for brain metastasis in patients with malignant melanoma, breast cancer, and non-small cell lung cancer. Proc Am Soc Clin Oncol 22:102 (abstract 407)

    Google Scholar 

  35. Furonaka O, Takeshima Y, Awaya H, et al. (2005) Aberrant methylation and loss of expression of O-methylguanine-DNA methyltransferase in pulmonary squamous cell carcinoma and adenocarcinoma. Pathol Int 55:303–309

    Article  PubMed  CAS  Google Scholar 

  36. Pirzkall A, Debus J, Lohr F, et al. (1998) Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 16:3563–3569

    PubMed  CAS  Google Scholar 

  37. Aoyama H, Shirato H, Tago M, et al. (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491

    Article  PubMed  CAS  Google Scholar 

  38. Chougule PB, Burton-Williams M, Saris S (2000) Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both. Int J Radiat Oncol Biol Phys 48(Suppl. 1):114

    Google Scholar 

  39. Manon R, O’Neill AM, Knisel JP, et al. (2005) A phase II trial of radiosurgery (RS) for one to three newly diagnosed brain metastases from renal cell, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol 23:8870–8876

    Article  PubMed  Google Scholar 

  40. Regine WF, Huhn JL, Patchell RA, et al. (2002) Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys 52:333–338

    PubMed  Google Scholar 

  41. Meyers CA, Smith JA, Bezjak A, et al. (2004) Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22:157–165

    Article  PubMed  CAS  Google Scholar 

  42. Meyers CA (2000) Neurocognitive dysfunction in cancer patients. Oncology (Huntington) 14:75–79

    CAS  Google Scholar 

  43. Crossen JR, Garwood D, Glatstein E, et al. (1994) Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12:627–642

    PubMed  CAS  Google Scholar 

  44. Lee AW, Kwong DL, Leung SF, et al. (2002) Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time. Int J Radiat Oncol Biol Phys 53:75–85

    Article  PubMed  Google Scholar 

  45. Mehta MP, Shapiro WR, Glantz MJ, et al. (2002) Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. J Clin Oncol 20:3445–3453

    Article  PubMed  CAS  Google Scholar 

  46. Gregor A, Cull A, Stephens RJ, et al. (1997) Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial: United Kingdom Coordinating Committee for Cancer Res (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 33: 1752–1758

    Article  PubMed  CAS  Google Scholar 

  47. Penitzka S, Steinvorth S, Sehlleier S, et al. (2002) Assessment of cognitive function after preventive and therapeutic whole brain irradiation using neuropsychological testing. Strahlenther Onkol 178:252–258

    Article  PubMed  Google Scholar 

  48. Shibamoto Y, Baba F, Oda K, et al. (2008) Incidence of brain atrophy and decline in mini-mental state examination score after whole-brain radiotherapy in patients with brain metastases: a prospective study. Int J Radiat Oncol Biol Phys 72:1168–1173

    PubMed  Google Scholar 

  49. Corn BW, Moughan J, Knisely JPS, et al. (2008) Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118. Int J Radiat Oncol Biol Phys 71:71–78

    PubMed  Google Scholar 

  50. Welzel G, Fleckenstein K, Schaefer J, et al. (2008) Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Int J Radiat Oncol Biol Phys 72:1311–1318

    PubMed  Google Scholar 

  51. Monje ML, Palmer T (2003) Radiation injury and neurogenesis. Curr Opin Neurol 16:129–134

    Article  PubMed  Google Scholar 

  52. Peissner W, Kocher M, Treuer H, et al. (1999) Ionizing radiation-induced apoptosis of proliferating stem cells in the dentate gyrus of the adult rat hippocampus. Brain Res Mol Brain Res 71: 61–68

    Article  PubMed  CAS  Google Scholar 

  53. Shi L, Molina DP, Robbins ME, et al.(2008) Hippocampal neuron number is unchanged 1 year after fractionated whole-brain irradiation at middle age. Int J Radiat Oncol Biol Phys 71:526–532

    PubMed  Google Scholar 

  54. Barani IJ, Benedict SH, Lin PS (2007) Neural stem cells: implications for the conventional radiotherapy of central nervous system malignancies. Int J Radiat Oncol Biol Phys 68:324–333

    PubMed  Google Scholar 

  55. Ghia A, Tome WA, Thomas S, et al. (2007) Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation. Int J Radiat Oncol Biol Phys 68:971–977

    PubMed  Google Scholar 

  56. Barani IJ, Cuttino LW, Benedict SH, et al. (2007) Neural stem cell-preserving external-beam radiotherapy of central nervous system malignancies. Int J Radiat Oncol Biol Phys 68:978–985

    PubMed  Google Scholar 

  57. Tomita N, Kodaira T, Tachibana H, et al. (2008) Helical tomotherapy for brain metastases: dosimetric evaluation of treatment plans and early clinical results. Technol Cancer Res Treat 7: 417–424

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan

    Yuta Shibamoto, Chikao Sugie & Hiromitsu Iwata

Authors
  1. Yuta Shibamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chikao Sugie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiromitsu Iwata
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuta Shibamoto.

About this article

Cite this article

Shibamoto, Y., Sugie, C. & Iwata, H. Radiotherapy for metastatic brain tumors. Int J Clin Oncol 14, 281–288 (2009). https://doi.org/10.1007/s10147-009-0915-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-009-0915-2

Key words

Search

Navigation